Innovation Pharmaceuticals Inc (IPIX)

[kfcyahoo]

"I've long felt that B for IBD-related issues could be the defining moments for IPIX. This recent journal article emphasizes what seem to be the strong suits of B for IBD related issues. We can only hope Leo find the money and the wisdom to follow through here effectively."

I first felt K(kevetrin) could be the defining moment based on company statements, etc. I lost hope with K after a twenty person phase 2 resulted in 2 patients enrolled followed by encouraging words by the company of that 2 patient study- silence since.

Then there was P(prurisol).~270 days late and many shareholder dollars short of even close- after accolades by management prior to WAY LATE results.

B for ibd remains to be seen- heard by only forward looking statements from "management"

B for C we may see.

Holy Crap.